Clinical Microbiology and Infection, Год журнала: 2024, Номер unknown
Опубликована: Сен. 1, 2024
Язык: Английский
Clinical Microbiology and Infection, Год журнала: 2024, Номер unknown
Опубликована: Сен. 1, 2024
Язык: Английский
Опубликована: Авг. 29, 2024
Whereas there is an increasing number of scientific publications investigating the optimal anti-biotic treatment for diabetic foot infections, we are lacking corresponding data in adult non-diabetic (postsurgical) infection population. We therefore established one largest single-center databases on this topic and retrospectively investigate failures a combined sur-gical antibiotic therapy surgical site infections. Overall, 17.4% episodes expe-rienced any therapeutic failures; especially among infected ankle prostheses. In contrast, neither age, biological sex, pathogens, duration post-debridement treatment, debridement, or use negative-pressure wound care could alter failure risk. multivariate logistic regression analyses, postsur-gical was completely indifferent (as continuous variable with odds ratio 1.0, 95% confidence interval 0.96-1.03), when stratified into inter-tertiary groups. Our results poten-tially enable shorter applications systemic antibiotics favor better stewardship Consecutive prospective-randomized trials under way to identify eligible patient populations potentially durations infections after elective surgery.
Язык: Английский
Процитировано
1Journal of Clinical Medicine, Год журнала: 2023, Номер 12(21), С. 6808 - 6808
Опубликована: Окт. 27, 2023
(1) Objectives: This study investigated the optimal duration of antibiotic therapy and determined risk factors associated with relapse in patients culture-proven septic arthritis native joints. (2) Methods: A retrospective review was conducted on aged ≥18 years diagnosed joint arthritis, bacteria isolated from joints and/or blood. The exclusion criteria were prosthetic infections cases no identified microorganisms. outcomes assessed remission groups. (3) Results: Among 479 137 met inclusion criteria, a median follow-up 2.7 years. rate 9.5%, which mainly occurred within 30 days after treatment completion. Compared group, group showed significantly higher proportion that received for ≤ 4 weeks (4.8% vs. 46.2%, p < 0.001), synovial fluid white blood cell (WBC) counts ≥150 × 103/mm3 (25.3% 60.0%, = 0.030), acute kidney injury (19.2% 50%, 0.024), extended-spectrum beta-lactamases-producing Enterobacteriaceae (0.8 15.4%, 0.024). Independent as (odds ratio (OR), 25.47; 95% confidence interval (CI), 1.57-412.33; 0.023) WBC (OR, 17.46; CI, 1.74-175.62; 0.015). (4) Conclusions: Patients require vigilant monitoring relapse, particularly when treated regimens administered less than four or aspirates exhibit elevated at diagnosis.
Язык: Английский
Процитировано
3Clinical Microbiology and Infection, Год журнала: 2023, Номер 29(9), С. 1117 - 1119
Опубликована: Июнь 21, 2023
Язык: Английский
Процитировано
2Current Opinion in Infectious Diseases, Год журнала: 2023, Номер 36(6), С. 462 - 472
Опубликована: Сен. 21, 2023
Purpose of review This will describe role shorter antibiotic therapies, early switch from intravenous to oral therapy, and artificial intelligence in infectious diseases. Recent findings There is evidence that courses antibiotics are noninferior standard durations therapy. has been demonstrated with Enterobacterales bacteremia can be treated 7 days community acquired pneumonia 3 ventilator associated just The conversion therapy treating bacteremia, endocarditis bone joint infections safe effective reduces line complications costs. Also, for clean surgical procedures only one dose needed, but it should the most which cefazolin. means avoiding clindamycin, removing penicillin allergies where possible improved outcomes. Finally, incorporate into using wisely rapidly emerging still stages. Summary In wisely, targeting such as low hanging fruit. future could automate a lot this work exciting needs proven. Video abstract http://links.lww.com/COID/A50
Язык: Английский
Процитировано
2Current Infectious Disease Reports, Год журнала: 2023, Номер 25(12), С. 281 - 291
Опубликована: Ноя. 20, 2023
Язык: Английский
Процитировано
2Cureus, Год журнала: 2024, Номер unknown
Опубликована: Март 30, 2024
Antibiotics have played a pivotal role in modern medicine, drastically reducing mortality rates associated with bacterial infections. Despite their significant contributions, the emergence of antibiotic resistance has become formidable challenge, necessitating re-evaluation use practices. The widespread belief clinical practice that bactericidal antibiotics are inherently superior to bacteriostatic ones lacks consistent support from evidence randomized controlled trials (RCTs). With latest evidence, certain infections demonstrated equal or even efficacy agents. Furthermore, within practice, there is tendency indiscriminately order urine cultures for febrile patients, cases where alternative etiologies might be present. Consequently, upon obtaining positive culture result, patients often receive antimicrobial prescriptions despite absence indications warranting such treatment. it prevailing notion among physicians extended durations therapy confer potential benefits and mitigate resistance. Contrary this belief, empirical refutes assertions. This article aims address common myths misconceptions field infectious diseases.
Язык: Английский
Процитировано
0Clinical Microbiology and Infection, Год журнала: 2024, Номер unknown
Опубликована: Сен. 1, 2024
Язык: Английский
Процитировано
0